Skip to main content

Experimental Biology 2022 Main banner

Tweets by Experimental Biology 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Ashley Nilson

Presenting Author
National Institute of Neurological Disorders and Stroke

Disclosure information not submitted.

Presentation(s):

537.10 - Characterization and Chemical Optimization of the D2 Dopamine Receptor-Selective Antagonist, ML321, Identifies Lead Compounds for the Clinical Treatment of Neuropsychiatric Disorders
Tuesday, April 5, 2022
2:27 PM – 2:36 PM